Clinical Trial Update: Survey of Inhibitors in Plasma-Product Exposed Toddlers [Phase 4]

View source ↗

Summary

Phase 4 clinical trial results from a survey investigating inhibitors in toddlers with Hemophilia A who were exposed to plasma-derived products.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Snippet

Sponsor: Fondazione Angelo Bianchi Bonomi | Conditions: Hemophilia A | Phase 4 | Status: COMPLETED | Results posted: 2017-04-07